Ardelyx Stock (NASDAQ: ARDX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 2.788K / 6.266M |
Day Range | - - - |
52 Wk Range | 3.160 - 10.130 |
Market Cap | $1.724B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 34 |
Short Interest | 13.13% |
Days to Cover | 5.93 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Ardelyx (NASDAQ: ARDX) through any online brokerage.
Other companies in Ardelyx’s space includes: Immunome (NASDAQ:IMNM), Twist Bioscience (NASDAQ:TWST), Avidity Biosciences (NASDAQ:RNA), 4D Molecular Therapeutics (NASDAQ:FDMT) and Syndax Pharmaceuticals (NASDAQ:SNDX).
The latest price target for Ardelyx (NASDAQ: ARDX) was reported by Piper Sandler on Friday, February 23, 2024. The analyst firm set a price target for 15.00 expecting ARDX to rise to within 12 months (a possible 102.43% upside). 14 analyst firms have reported ratings in the last year.
The stock price for Ardelyx (NASDAQ: ARDX) is $7.41 last updated Today at March 28, 2024 at 7:00 AM EDT.
There are no upcoming dividends for Ardelyx.
Ardelyx’s Q1 earnings are confirmed for Wednesday, May 1, 2024.
There is no upcoming split for Ardelyx.
Ardelyx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.